Assay Name | Tissue | Target Gene ID | Target HGNC Symbol | Target UniProt ID | Response | AC50 value |
---|
CCTE_Deisenroth_AIME_384WELL_LUC_Active | Mammary Gland/Breast | 2099 | ESR1 | P03372 | Gain | 53.84 μM |
CCTE_Deisenroth_AIME_384WELL_LUC_Inactive | Mammary Gland/Breast | 2099 | ESR1 | P03372 | Gain | 77.31 μM |
CCTE_Deisenroth_AIME_384WELL_LUC_Shift | Mammary Gland/Breast | 2099 | ESR1 | P03372 | Activatory | 64.22 μM |
NVS_ENZ_hElastase | | 1991 | ELANE | P08246 | Loss | 46.87 μM |
NVS_GPCR_hDRD4.4 | | 1815 | DRD4 | P21917 | Loss | 35.48 μM |
ATG_Ahr_CIS | Liver | 196 | AHR | P35869 | Activatory | 1.90 μM |
ATG_E_Box_CIS | Liver | 7391 | USF1 | P22415 | Inhibitory | 2.65 μM |
ATG_ERE_CIS | Liver | 2099 | ESR1 | P03372 | Activatory | 2.89 μM |
ATG_IR1_CIS | Liver | 9971 | NR1H4 | Q96RI1 | Inhibitory | 1.92 μM |
ATG_NRF2_ARE_CIS | Liver | 4780 | NFE2L2 | Q16236 | Activatory | 2.81 μM |
ATG_ERa_TRANS | Liver | 2099 | ESR1 | P03372 | Gain | 2.44 μM |
BSK_4H_Eotaxin3 | Vascular | 10344 | CCL26 | Q9Y258 | Inhibitory | 2.48 μM |
BSK_BE3C_MMP1 | Lung | 4312 | MMP1 | P03956 | Activatory | 1.42 μM |
BSK_CASM3C_Thrombomodulin | Vascular | 7056 | THBD | P07204 | Activatory | 2.24 μM |
BSK_LPS_TissueFactor | Vascular | 2152 | F3 | P13726 | Activatory | 0.59 μM |
ATG_Ahr_CIS | Liver | 196 | AHR | P35869 | Activatory | 0.40 μM |
ATG_DR4_LXR_CIS | Liver | 7376|10062 | NR1H2|NR1H3 | P55055|Q13133 | Inhibitory | 1.25 μM |
ATG_ERE_CIS | Liver | 2099 | ESR1 | P03372 | Activatory | 1.48 μM |
ATG_HIF1a_CIS | Liver | 3091 | HIF1A | Q16665 | Activatory | 2.30 μM |
ATG_NRF2_ARE_CIS | Liver | 4780 | NFE2L2 | Q16236 | Activatory | 0.93 μM |
ATG_Oct_MLP_CIS | Liver | 5451 | POU2F1 | P14859 | Activatory | 1.21 μM |
ATG_RORE_CIS | Liver | 6096|6095|6097 | RORB|RORA|RORC | P51449|Q92753|P35398 | Activatory | 1.44 μM |
ATG_ERa_TRANS | Liver | 2099 | ESR1 | P03372 | Gain | 1.72 μM |
ATG_Ahr_CIS | Liver | 196 | AHR | P35869 | Activatory | 1.41 μM |
ATG_AP_1_CIS | Liver | 3725|2353 | JUN|FOS | P01100|P05412 | Activatory | 2.33 μM |
ATG_EGR_CIS | Liver | 1958 | EGR1 | P18146 | Activatory | 2.26 μM |
ATG_ERE_CIS | Liver | 2099 | ESR1 | P03372 | Activatory | 2.82 μM |
ATG_NRF2_ARE_CIS | Liver | 4780 | NFE2L2 | Q16236 | Activatory | 1.91 μM |
ATG_Ahr_CIS | Liver | 196 | AHR | P35869 | Activatory | 0.68 μM |
ATG_DR4_LXR_CIS | Liver | 7376|10062 | NR1H2|NR1H3 | P55055|Q13133 | Inhibitory | 1.70 μM |
ATG_E_Box_CIS | Liver | 7391 | USF1 | P22415 | Inhibitory | 1.59 μM |
ATG_ERE_CIS | Liver | 2099 | ESR1 | P03372 | Activatory | 2.58 μM |
ATG_HSE_CIS | Liver | 3297 | HSF1 | Q00613 | Activatory | 119.61 μM |
ATG_IR1_CIS | Liver | 9971 | NR1H4 | Q96RI1 | Inhibitory | 0.62 μM |
ATG_NRF2_ARE_CIS | Liver | 4780 | NFE2L2 | Q16236 | Activatory | 0.71 μM |
ATG_ERa_TRANS | Liver | 2099 | ESR1 | P03372 | Gain | 2.43 μM |
CPHEA_Stoker_NIS_Inhibition_RAIU | Kidney | 6528 | SLC5A5 | Q92911 | Loss | 50.00 μM |
CCTE_GLTED_hDIO2 | | 1734 | DIO2 | | Loss | 70.00 μM |
CCTE_GLTED_hDIO3 | | 1735 | DIO3 | | Loss | 65.85 μM |
TOX21_ELG1_LUC_Agonist | Kidney | 79915 | ATAD5 | Q96QE3 | Gain | 58.24 μM |
TOX21_ERa_BLA_Agonist_ratio | Kidney | 2099 | ESR1 | P03372 | Gain | 52.60 μM |
TOX21_ERa_LUC_VM7_Agonist | Breast | 2099 | ESR1 | P03372 | Gain | 46.22 μM |
TOX21_CAR_LUC_Agonist | Liver | 9970 | NR1I3 | Q14994 | Gain | 31.55 μM |
TOX21_p450_CYP2D6_Antagonist | | 1565 | CYP2D6 | P10635 | Loss | 57.64 μM |
TOX21_p450_CYP1A2_Antagonist | | 1544 | CYP1A2 | P05177 | Loss | 0.84 μM |
TOX21_ERa_LUC_VM7_Agonist | Breast | 2099 | ESR1 | P03372 | Gain | 32.07 μM |
TOX21_VDR_BLA_Agonist_ch2 | Kidney | | | | Gain | 57.11 μM |
TOX21_p450_CYP2D6_Antagonist | | 1565 | CYP2D6 | P10635 | Loss | 57.47 μM |
TOX21_p450_CYP2C19_Antagonist | | 1557 | CYP2C19 | P33261 | Loss | 41.95 μM |
TOX21_p450_CYP1A2_Antagonist | | 1544 | CYP1A2 | P05177 | Loss | 0.89 μM |